ARKK Holdings of 10x Genomics (TXG) - Updated Daily
Single Cell GenomicsCell AnalyticsLab EquipmentLab EquipmentSpatial GenomicsWorkflow Automation
Key Statistics
Statistics
| ⚖️Weighting | 🧢Market Cap |
|---|---|
| 1.56% | $6.18b |
| 🏋🏿♂️Weight Rank In ARKK | 🌏Country |
| 22 | 🇺🇸United States |
| 🏋️♀️Weight Rank Across All Funds | 💳ARK Estimated Cost Average |
| 22 | $153.19 |
| 🎫ARK Ownership Percent | |
| 2.33% | |
| Description | |
|---|---|
| advancing human health requires a greater understanding of biology, and that understanding starts with the cell. we enable researchers to drive exponential progress in oncology, immunology, neuroscience, and more with novel single cell, spatial, and in situ tools that have been cited in over 3,000 publications and continually improved by our dedicated scientific team. our aim: to develop innovative instruments, reagents, and software that allow you to see your biological system at a resolution that matches its complexity. | |
| Website | |
| 10xgenomics.com |
Other ETFs That Hold TXG
Research Notes and Commentary for TXG
No Research Notes Found for TXG